Retail
Sycamore Partners is reportedly considering a trade sale of Boots rather than a London IPO, with potential suitors said to include the Weston family’s Wittington Investments and Australia-listed Sigma Healthcare. Sigma confirmed it had held preliminary discussions, although there is no certainty that a transaction will proceed (Alliance News, 10 June 2026).
TG Jones is seeking approval for a restructuring plan that would involve significant rent reductions, rent-free periods of up to three years and the closure of 150 stores, as it looks to reduce its property cost base. The proposal has prompted legal opposition from major landlords, including British Land, Landsec, M&G and NewRiver REIT, which argue that the plan places a disproportionate share of the restructuring burden on property owners. A High Court hearing is scheduled for later in June (Property Week, 08 June 2026).
Logistics
GXO has signed a lease for around 26,000 sq m at 7R Park Lavičky in the Czech Republic, where it will operate a 3PL logistics centre supporting L’Oréal’s European distribution. The build-to-suit facility is being developed by 7R and WOOD & Company, will include energy-efficient features and hazardous materials storage, and is targeting BREEAM Excellent certification (Eurobuild CEE, 10 June 2026).
Office
Tishman Speyer has signed five new leases totalling 81,000 sq ft at its Belvedere SW1 campus in London, supporting the repositioning of the mixed-use property following its acquisition in 2025. AI customer experience platform Sierra has taken 41,800 sq ft of office space, while The Travel Corporation has signed for 23,100 sq ft, relocating from nearby Victoria. Retail and amenity lettings include Honest Greens, Neko Health and Westminster City Council, reflecting early leasing momentum and continued demand for high-quality mixed-use space in Victoria (Property Week, 11 June 2026).
British Land launched Three Deal Porters, a 120,000 sq ft mixed-use office building at Canada Water, alongside its first letting to Foundervine. Foundervine will occupy 3,268 sq ft of Work Ready space, becoming the building’s first occupier and supporting British Land’s wider Canada Water commercial offering (British Land, 09 June 2026).
Other
GSK has agreed to acquire U.S. oncology biotech Nuvalent for $10.6bn, adding late-stage lung cancer treatments including zidesamtinib and neladalkib, both under FDA review. The deal, reportedly GSK’s largest acquisition in more than a decade, strengthens its precision oncology pipeline and is expected to support revenue growth from 2027 (LinkedIn News, 10 June 2026).
